Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 23 matches.
Page:
1
Refine your search to narrow the results.

Pooled Efficacy of Infliximab for the Treatment of Patients with Moderate-to-Severe Psoriasis

Presented at the AAD 64th Annual Meeting, San Francisco, California, March 2006

Condition
Psoriasis
Author
A. Menter, K. Papp, C. Guzzo, S. Li
Year
2006
Register & Request Access

Dapsone Gel 5% Is A Novel, Effective, And Safe Therapy For The Treatment Of Acne Vulgaris: 2 Controlled, Parellel-Design Studies (DAP0203/0204)

Presented at the Dermatology Nurses Association Meeting, San Francisco, California, March 2006

Condition
Acne Vulgaris
Author
E. Carter, B. Elewski, H. Sharata, E. Rafal, J. Roberts, A. Shalita, K. Papp, K. Loven
Year
2006
Register & Request Access

Levels of Response of Psoriasis Patients With Different Baseline Characteristics Treated With Etanercept

Presented at the AAD 64th Annual Meeting, San Francisco, California, March 2006

Condition
Psoriasis
Author
B. Strober, A. Gottlieb, C. Leonardi, K. Papp, M. Dunn, P. Peloso, A. Jahreis
Year
2006
Register & Request Access

The long-term efficacy and safety of new biological therapies for psoriasis

Archives of Dermatology Research. 2006 Jun;298(1):7-15. Epub 2006 Apr 25.

Journal
Archives of Dermatology Research (Arch Dermatol Res)
PubMed ID
16691429
Condition
Psoriasis
Author
Kim A. Papp
Year
2006
Register & Request Access

Etanercept and clinical outcomes, fatigue, and depression in psoriasis double-blind placebo-controlled randomised phase III trial

Lancet. 2006 Jan 7;367(9504):29-35.

Journal
Lancet
PubMed ID
16399150
Condition
Psoriasis
Author
Tyring, Gottlieb, Papp, Gordon, Leonardi, Wang, Lalla, Woolley, Jahreis, Zitnik, Cella, Krishnan
Year
2006
Register & Request Access

A randomized comparision of continuous vs intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

Journal of American Acadamy of Dermatology. 2007 Jan;56(1):31.e1-15. Epub 2006 Sep 6.

Presented at the 64th Annual Meeting of the American Academy of Dermatology, San Francisco, California, March 3-7, 2006

Journal
Journal of American Acadamy of Dermatology (JAAD)
PubMed ID
17097378
Condition
Psoriasis
Author
Menter, Feldman, Weinstein, Papp, Evans, Guzzo, Li, Dooley, Arnold, Gottlieb
Year
2006
Register & Request Access

Champion Phase III Trial Results Adalimumab Efficacy and Safety Compared with Methotrexate and Placebo in Patients with Moderate to Severe Psoriasis

Presented at EADV Rhodes, Greece, October 2006

Condition
Psoriasis
Author
J Saurat, G Sting, L Dubertret, K Papp, J Ortonne, K Unnebrink, M Kaul, A Camez
Year
2006
Register & Request Access

Long-term patient-reported outcomes Etanercept therapy in patients with psoriasis

American Academy of Dermatology 64th Annual Meeting, San Francisco, California, March 3-7, 2006

Condition
Psoriasis
Author
Christopher Griffiths, Kim Papp, John Koo, Gerald Krueger, Chiun-Fang Chiou, Meleana Dunn, Paul Peloso, Angelika Jahreis
Year
2006
Register & Request Access

Continued improvements in patient-reported outcomes with Etanercept in patients with psoriasis for up to 2.5 years

Presented at the AAD 64th Annual Meeting, San Francisco, California, March 2006

Condition
Psoriasis
Author
Christopher Griffiths, Kim Papp, John Koo, Gerald Krueger, Chiun-Fang Chiou, Meleana Dunn, Paul Peloso, Angelika Jahreis
Year
2006
Register & Request Access

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

International Journal of Dermatology 2006 May;45(5):605-14.

Journal
International Journal of Dermatology
PubMed ID
16700803
Condition
Psoriasis
Author
Kim A. Papp, Reni Bressinck, Scott Fretzin, Bernard Goffe, Steven Kempers, Kenneth B. Gordon, Ivor Caro, Patricia A. Walicke, Xiaolin Wang, Alan Menter on behalf of the Efalizumab Study Group
Year
2006
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login